Clinical Trial: A Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.

U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07412665) titled 'A Clinical Study GK01 Cell Injection in Subjects With Advanced Solid Tumors.' on Feb. 09.

Brief Summary: This study is an open-label, single-arm clinical trial to evaluate the safety, pharmacokinetics, and preliminary efficacy of GK01 in patients with advanced solid tumors.

Study Start Date: April 01

Study Type: INTERVENTIONAL

Condition: Advanced Solid Tumors

Intervention: DRUG: GK01 injection

Autologous tumor-reactive T cells injection

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Beijing Geekgene Technology Co., LTD

Disclaimer: Curated by HT Syndication....